San Diego, CA · Founded 2022 · Privately Held (backing)
Operator of a clinical-stage oncology platform intended to develop novel treatments for underserved cancers. Avenzo Therapeutics is based in San Diego, CA and was founded in 2022. It was valued at $590 million at its early-stage round in Aug 2025, the last priced event on record. It has raised $446 million across 2 recorded rounds; the latest was a $47.2 million early-stage round in Aug 2025.
PMV mark · valuation
$590.0M
Oct 2026
Priced at
its early-stage round
Aug 2025
Total raised
$445.9M
Last round
Early Stage VC
Aug 2025
Team — not yet on record
No current team members for Avenzo Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Avenzo Therapeutics with a free account
·The complete investor list: 15 names
·Watch Avenzo Therapeutics: the Monday email on marks, rounds and moves
